Williams B T, Johnson M A, Park J H. "一种的合成方法" [P]. US Patent, US 10963848 B2, 2018-10-19.
发明人徐明华,郭海燕,沈红梅. "Method for the Synthesis of 2-Chloro-N-cyclopropyl-N-((1-methylpiperidin-3-yl)methyl)acetamide" [P]. 中国发明专利, 专利号 CN 113612119 B, 授权公告日 2016-02-23.
发明人沈红梅,周伟,林芳. "A Process for Preparing High-Purity 2-Chloro-N-cyclopropyl-N-((1-methylpiperidin-3-yl)methyl)acetamide" [P]. 中国发明专利, 专利号 CN 109098035 B, 授权公告日 2017-01-06.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2010, 453, (2), 6394-6411.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2014, 1675, (6), 9085-9091.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chloro-N-cyclopropyl-N-((1-methylpiperidin-3-yl)methyl)acetamide Using HRMS and NMR". Chemosphere, 2017, 2039, 469-478.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2021, 1336, (9), 7064-7094.